[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

TransGenic Inc (2342) - Financial and Strategic SWOT Analysis Review

October 2021 | 39 pages | ID: T072E3D5A8FEN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
TransGenic Inc (2342) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

TransGenic Inc (TransGenic) is a biotechnology company which develops and distributes genetically engineered animals and antibodies and licensing of these activities. The company’s product portfolio and services include knockout mouse and phenotype database, custom production of antibodies and proteins, genetically engineered mice, custom production of knock out mouse, drug discovery and contract services for non-clinical study, support services, mouse related products and antibody related products. TransGenic provides gene analysis and nonclinical study using disease-animal model. The company’s technologies include genetically engineered mouse knock in mouse and knockout mouse; genome editing technology; exchangeable Gene-trap method, among others. It has Kobe research center located in Japan. TransGenic is headquartered in Fukuoka City, Japan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

TransGenic Inc - Key Facts
TransGenic Inc - Key Employees
TransGenic Inc - Key Employee Biographies
TransGenic Inc - Major Products and Services
TransGenic Inc - History
TransGenic Inc - Company Statement
TransGenic Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
TransGenic Inc - Business Description
Business Segment: Drug Discovery Support Business
Overview
Performance
Business Segment: TGBS
Overview
Performance
TransGenic Inc - Corporate Strategy
TransGenic Inc - SWOT Analysis
SWOT Analysis - Overview
TransGenic Inc - Strengths
TransGenic Inc - Weaknesses
TransGenic Inc - Opportunities
TransGenic Inc - Threats
TransGenic Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
TransGenic Inc, Recent Deals Summary

SECTION 5 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

TransGenic Inc, Key Facts
TransGenic Inc, Key Employees
TransGenic Inc, Key Employee Biographies
TransGenic Inc, Major Products and Services
TransGenic Inc, History
TransGenic Inc, Other Locations
TransGenic Inc, Subsidiaries
TransGenic Inc, Key Competitors
TransGenic Inc, Ratios based on current share price
TransGenic Inc, Annual Ratios
TransGenic Inc, Annual Ratios (Cont...1)
TransGenic Inc, Annual Ratios (Cont...2)
TransGenic Inc, Interim Ratios
TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
TransGenic Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

TransGenic Inc, Performance Chart (2017 - 2021)
TransGenic Inc, Ratio Charts
TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
TransGenic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021


More Publications